库库莫尔可以通过AKT/NF-κB通路缓解心脏重塑
Zhao Fang1, Shuang Li2, Feierkaiti Yushanjiang1
1Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China; Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
International immunopharmacology
|July 1, 2023
概括
库尔库莫尔是一种天然化合物,通过减少心脏功能障碍,纤维化和炎症来治疗心脏重塑具有前途. 它通过抑制AKT/NF-κB通路来保护心脏,为心血管疾病提供了潜在的新疗法.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏重塑是心血管疾病中一个关键的,但不太了解的过程,往往导致心力衰竭.
- 目前对心脏重塑的治疗选择有限,这突显了对新型治疗策略的需求.
研究的目的:
- 为了研究黄醇对心脏重塑的保护作用.
- 阐明库尔库莫尔在心脏重塑中的作用的潜在分子机制.
主要方法:
- 利用异二醇 (ISO) 诱导的动物模型研究心脏重塑.
- 评估了库尔库莫尔对心脏功能,纤维化,增大和电力改造的影响.
- 在心肌和心肌细胞模型中研究了curcumol对炎症和亡的影响.
- 探索了AKT/NF-κB信号通路在调解丸醇作用中的作用.
主要成果:
- 库尔库在ISO诱导模型中显著减轻了心脏功能障碍,心肌纤维化和过度缩小.
- 库尔库莫尔缓解了心脏电力改造,降低了心室的风险.
- 库尔库莫尔抑制了ISO和TGF-β1诱导的炎症和亡.
- 库尔库莫尔的保护作用是通过抑制AKT/NF-κB通路来实现的,AKT激动剂逆转了其益处.
结论:
- 库尔库莫尔证明了对心脏重塑的显著保护作用.
- 库库莫尔的治疗潜力在于其通过AKT/NF-κB通路抑制炎症,亡和纤维化的能力.
- 库尔库莫尔代表了开发心脏重塑和相关心血管疾病的新疗法的一个有希望的候选人.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K


